Quidel Corp (NASDAQ:QDEL)

248.26
Delayed Data
As of Oct 23
 +2.52 / +1.03%
Today’s Change
55.42
Today|||52-Week Range
306.72
+230.88%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$10.2B

Company Description

Quidel Corp. engages in the development, manufacture and market of rapid diagnostic testing solutions. Its portfolio includes rapid immunoassays, cardiac immunoassays, specialized diagnostic solutions and molecular diagnostic solutions. The products are directly sold to end users and distributors and for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies and wellness screening centers. The company was founded in 1979 and is headquartered in San Diego, CA.

Contact Information

Quidel Corp.
9975 Summers Ridge Road
San Diego California 92121
P:(858) 552-1100
Investor Relations:
(858) 646-8023

Employees

Shareholders

Mutual fund holders55.90%
Other institutional35.78%
Individual stakeholders13.78%

Top Executives

Douglas C. BryantPresident, Chief Executive Officer & Director
Robert Joseph BujarskiChief Operating Officer
Randall J. StewardChief Financial Officer
Werner KrollSenior Vice President-Research & Development
Karen S. GibsonSVP-Information Systems & Business Transformation